Artelo Biosciences Inc Sustainability Reports
Artelo Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that modulate the endocannabinoid system. The company develops new chemical entities to treat pain, cancer, anxiety, and other therapeutic areas.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
3 reports from 2021 to 2025
Company Profile
Artelo Biosciences Inc. is a clinical-stage biopharmaceutical company focused on developing therapies that modulate the endocannabinoid system. The company develops new chemical entities to treat pain, cancer, anxiety, and other therapeutic areas.
Reports
3 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
